Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics Raises $5M in Series A, Plans to Expand Bioinformatics Platform for Proteomics

NEW YORK, Feb. 3 (GenomeWeb News) - GenoLogics Life Sciences has raised $5 million in venture capital in a Series A funding round, the Victoria, Canada-based company said today.


GenoLogics plans to use the funding to expand its sales and marketing, product development, and corporate development. The company's first product is an open bioinformatics platform for proteomics research.


The financing was led by OVP Venture Partners of Seattle and Yaletown Venture Partners of Vancouver. Working Opportunity Fund, managed by Growth Works Capital of Vancouver, also participated in the round.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.